These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 1709421

  • 21. Concentration gradients of monoamine metabolites in human cerebrospinal fluid.
    Sjöström R, Ekstedt J, Anggård E.
    J Neurol Neurosurg Psychiatry; 1975 Jul; 38(7):666-8. PubMed ID: 1159438
    [Abstract] [Full Text] [Related]

  • 22. Intraspinal pressure influences CSF disposition of tryptophan and 5-HIAA.
    Eklundh T, Nordin C.
    Neuropsychobiology; 2001 Jul; 44(2):84-7. PubMed ID: 11490176
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Increased monoamine metabolite concentrations and cholinesterase activities in cerebrospinal fluid of patients with acute stroke.
    Wester P, Puu G, Reiz S, Winblad B, Wester PO.
    Acta Neurol Scand; 1987 Dec; 76(6):473-9. PubMed ID: 3434205
    [Abstract] [Full Text] [Related]

  • 26. Cerebrospinal fluid monoamine markers are decreased in dementia of the Alzheimer type with extrapyramidal features.
    Kaye JA, May C, Daly E, Atack JR, Sweeney DJ, Luxenberg JS, Kay AD, Kaufman S, Milstien S, Friedland RP.
    Neurology; 1988 Apr; 38(4):554-7. PubMed ID: 2451190
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. CSF neurotransmitter markers in Alzheimer's disease.
    Beal MF, Growdon JH.
    Prog Neuropsychopharmacol Biol Psychiatry; 1986 Apr; 10(3-5):259-70. PubMed ID: 2879317
    [Abstract] [Full Text] [Related]

  • 31. Monoamine metabolites in normal human cerebrospinal fluid and in degenerative diseases of the central nervous system.
    González-Quevedo A, García JC, Fernández R, Fernández Cartaya L.
    Bol Estud Med Biol; 1993 Apr; 41(1-4):13-9. PubMed ID: 7521168
    [Abstract] [Full Text] [Related]

  • 32. Simultaneous measurement of monoamine metabolites and 5-methyltetrahydrofolate in the cerebrospinal fluid of children.
    Akiyama T, Hayashi Y, Hanaoka Y, Shibata T, Akiyama M, Nakamura K, Tsuyusaki Y, Kubota M, Yoshinaga H, Kobayashi K.
    Clin Chim Acta; 2017 Feb; 465():5-10. PubMed ID: 27940130
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Developmental variations in CSF monoamine metabolites during childhood.
    Hedner J, Lundell KH, Breese GR, Mueller RA, Hedner T.
    Biol Neonate; 1986 Feb; 49(4):190-7. PubMed ID: 2423144
    [Abstract] [Full Text] [Related]

  • 36. [Physiopathology of neurotransmitter metabolites in the cerebrospinal fluid in brain tumors].
    Massarotti M.
    Minerva Med; 1984 May 19; 75(21):1279-86. PubMed ID: 6203057
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. The P300 event-related potentials in dementia of the Alzheimer type. Correlations between P300 and monoamine metabolites.
    Ito J, Yamao S, Fukuda H, Mimori Y, Nakamura S.
    Electroencephalogr Clin Neurophysiol; 1990 May 19; 77(3):174-8. PubMed ID: 1691969
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.